Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data
暂无分享,去创建一个
Bette C Liu | A. Dey | K. Canfell | P. McIntyre | R. Menzies | Megan A. Smith | Bette Liu
[1] E. Banks,et al. Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study. , 2015, Vaccine.
[2] Paul Badcock,et al. Knowledge about and experience of sexually transmissible infections in a representative sample of adults: the Second Australian Study of Health and Relationships. , 2014, Sexual health.
[3] J. Brotherton,et al. Assessing HPV vaccine coverage in Australia by geography and socioeconomic status: are we protecting those most at risk? , 2014, Australian and New Zealand journal of public health.
[4] Deborah Bateson,et al. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study. , 2014, The Lancet. Infectious diseases.
[5] M. Hickman,et al. Examining inequalities in the uptake of the school-based HPV vaccination programme in England: a retrospective cohort study. , 2014, Journal of public health.
[6] Basil Donovan,et al. Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey. , 2014, Vaccine.
[7] D. Mesher,et al. Coverage of the English national human papillomavirus (HPV) immunisation programme among 12 to 17 year-old females by area-level deprivation score, England, 2008 to 2011. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[8] J. Seidel,et al. Social equity in Human Papillomavirus vaccination: a natural experiment in Calgary Canada , 2013, BMC Public Health.
[9] J. Hadler,et al. Declining Rates of High-Grade Cervical Lesions in Young Women in Connecticut, 2008–2011 , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[10] J. Brotherton,et al. Human papillomavirus vaccination and cervical cancer screening by socioeconomic status, Victoria , 2012, The Medical journal of Australia.
[11] A. Giuliano,et al. Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study. , 2011, The Journal of infectious diseases.
[12] D. Whynes,et al. Explaining variation in the uptake of HPV vaccination in England , 2011, BMC public health.
[13] J. Palefsky,et al. Human papillomavirus-related disease in men: not just a women's issue. , 2010, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[14] R. Railkar,et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. , 2009, The Journal of infectious diseases.
[15] J. Brotherton. How much cervical cancer in Australia is vaccine preventable? A meta-analysis. , 2008, Vaccine.
[16] Bruce K Armstrong,et al. Remoteness of residence and survival from cancer in New South Wales , 2004, The Medical journal of Australia.
[17] B. Chait,et al. Supervillin binding to myosin II and synergism with anillin are required for cytokinesis , 1992, Molecular biology of the cell.
[18] Bette C Liu,et al. Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data. , 2015, The Journal of infectious diseases.
[19] C. Andrzejewski,et al. BMC Infectious Diseases , 2006 .